ROCHE 0245 ROCHE 0245 Pill - green yellow capsule/oblong, 22mm
Generic Name: saquinavir
Pill with imprint ROCHE 0245 ROCHE 0245 is Green / Yellow, Capsule/Oblong and has been identified as Invirase 200 mg. It is supplied by Roche Laboratories.
Invirase is used in the treatment of HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Invirase 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ROCHE 0245 ROCHE 0245
Invirase
- Generic Name
- saquinavir
- Imprint
- ROCHE 0245 ROCHE 0245
- Strength
- 200 mg
- Color
- Green / Yellow
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- Inactive Ingredients
-
lactose anhydrous,
microcrystalline cellulose,
povidone k30,
sodium starch glycolate type A potato,
magnesium silicate,
magnesium stearate,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
FD&C Blue No. 2,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00004-0245 (Discontinued) | Roche |
| 54868-3699 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about Invirase (saquinavir)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: protease inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.